Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome (MDS)

Explore clinical trials studying Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

57 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome (MDS) trial results

Completed

Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02979366

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Patient Care Location: Smilow Cancer Hospital at Yale New Haven, Connecticut, United States
  • The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine Houston, Texas, United States
  • The Alfred Hospital Department of Haematology Melbourne, Australia
  • Royal Melbourne Hospital, Department of Clinical Haematology and BMT Service Melbourne, Australia
View Trial Details
Completed

A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes

NCT03516591

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

NCT01816230

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Steven and Alexandra Cohen Children's Medical Center New York, United States
View all 15 locations
View Trial Details
Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions